Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis

Multiple Sclerosis

Volumn 9, Issue 6, 2003, Pages 621-626

  Marrie, Ruth Ann ^a   Miller, Deborah M ^a   Chelune, Gordon J ^a   Cohen, Jeffrey A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cognition; Health related quality of life; MSQLI; Multiple sclerosis; Reliability; Self report; Validity

Indexed keywords

ACCURACY; ADULT; AGE; ARTICLE; BLADDER FUNCTION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATION; ETHNIC DIFFERENCE; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; QUALITY OF LIFE; RELIABILITY; SELF REPORT; VALIDATION PROCESS; VISION;

ADULT; COGNITION DISORDERS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0344961115     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458503ms971oa     Document Type: Article

References (34)

1. Cella DF, Dineen K, Arnason B, Reder A. Validation of the Function Assessment of Multiple Sclerosis quality of life instrument. Neurology 1996; 47: 129-39.
2. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996; 23: 99-103.
3. Nortvedt MW, Riise T, Myhr K-M, Nyland HI: Quality of life in multiple sclerosis: Measuring the disease effects more broadly. Neurology 1999; 53: 1098-103.
4. Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: Part II: Quality of life. Can J Neurol Sci 1998; 25: 31-38.
5. Hermann B, Vickrey B, Hays RD, Cramer J, Devinsky O, Meador K et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996; 25: 113-18.
6. Rudick RA, Miller DM, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis: Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 1992; 49: 1237-42.
7. Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H, Paty DW. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler 1999; 5; 251-59.
8. Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF et al. Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology 2002; 59: 679-87.
9. Amato MP, Giuseppina P, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis: Patterns, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 1995; 52: 168-72.
10. Beatty WW, Goodkin DE, Hersgaard D, Monson N. Clinical and demographic predictors of cognitive performance in multiple sclerosis: Do diagnostic type, disease duration, and disability matter? Arch Neurol 1990; 47: 305-308.
11. Lyon-Caen O, Jouvent R, Hauser S, Caunu M, Benoit N, Widlocher D et al. Cognitive function in recent-onset demyelination disease. Arch Neurol 1986; 43: 1138-41.
12. Peyser JM, Edwards KR, Poser CM, Filskov SB. Cognitive function in patients with multiple sclerosis. Arch Neurol 1980; 37: 577-79.
13. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis I: Frequency, patterns, and predictions. Neurology 1991; 41: 685-91.
14. Kenealy PM, Beaumont JG, Lintern T, Murrell R. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22: 125-31.
15. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
16. Benedict RHB, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J et al. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin Neuropsychol 2002; 16: 381-97.
17. Taylor MJ, Heaton RK. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 2001; 7: 867-74.
18. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, Larocca NG. Multiple Sclerosis Quality of Life Inventory: A User's Manual. National Multiple Sclerosis Society, 1997.
19. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: Cross-sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997; 314: 1580-83.
20. Sprangers MA, Aronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidemiol 1992; 45: 743-60.
21. Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Clinical significance of the Multiple Sclerosis Functional Composite: Relationship to patient-reported quality of life. Arch Neurol 2000; 57: 1319-24.
22. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
23. Hakstian AR, Whalen TE. A k-sample significance test for independence alpha coefficients. Biometrika 1976; 41: 219-31.
24. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Administration and Scoring Manual for the Multiple Sclerosis Functional Composite Measure (MSFC). National Multile Sclerosis Society, 2001.
25. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996; 46: 907-11.
26. SAS Institute Inc. SAS V8.2. 1999.
27. Baier ML, Miller DM. How consistent is self-reported health-related quality of life in the face of cognitive impairment in MS patients. Presented at International Society for Quality of Life Research, 7-10 November, Amsterdam, The Netherlands, 2001.
28. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairement. Psychosomatic Med 2002; 64: 510-19.
29. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.
30. Nowinski JK, LoPiccolo J. Assessing sexual behavior in couples. J Sex Marital Ther 1979; 5: 224-43.
31. Sherbourne CD, Stewart AL. The MOS Social Support Survey. Soc Sci Med 1991; 32: 705-14.
32. Stewart AL, Ware JE. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992.
33. Turnball GK, Hoare C, Ritvo PG, Fisk JD, Murray TJ. The assessment of bowel and bladder dysfunction in clinic attending MS patients. Presented at Department of Medicine Research Symposium, Dalhousie University, Halifax, Nova Scotia, May 1993.
34. Sullivan JJL, Edgley K, Dehoux E. A survey of multiple sclerosis Part 1: Perceived cognitive problems and compensatory strategy use. Can J Rehab 1990; 4: 99-105.